跳至主要内容
临床试验/ITMCTR2100004334
ITMCTR2100004334招募中1 期

Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and Western Medicine

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • (1) The study subjects should meet the following diagnostic criteria: ? Western medical diagnostic criteria: New York criteria revised by the American College of Rheumatology in 1984;(2) TCM syndrome diagnosis criteria: according to Professor Jiao Shude's Big Stoop (Ankylosing Spondylitis) Etiology, Pathogenesis and Syndrome Differentiation Discussion revised.
  • (2) Active patients with ankylosing spondylitis (Basdai >4);
  • (3) Aged 18-70 years(inclusive)
  • (4) The use of NSAIDs has been stopped for 2 weeks;
  • (5) The use of remission anti-rheumatic drugs (DMARDs) has been stopped for 1 month;
  • (6) The use of biological agents has been stopped for 3 months;
  • (7) Signed the informed consent.

排除标准

  • Potential subjects meeting the inclusion criteria will be excluded if they meet any of the following criteria:
  • (1) Peripheral articular AS (classification standard of AS according to 2009ACR);
  • (2) Patients with advanced disease, complete spine rigidity and severe joint deformity indicated by clinical or imaging;
  • (3) The baseline examination showed abnormal platelet, white blood cell and hemoglobin in the following laboratory indicators, which had clinical significance;Serum creatinine, AST, ALT, ALP, GGT, TBIL were 1.25 times higher than normal.The urine routine was abnormal, and the erythrocyte > / HP and occult blood were positive in stool routine, which had clinical significance.
  • (4) Pregnant women, lactating women, or women who intend to become pregnant within one year;
  • (5) Participating in other clinical trials;
  • (6) Those who have received treatment under this plan but have no effect;
  • (7) Patients with severe primary heart, liver, kidney and other organ function impairment or other possible interference with follow-up evaluation;
  • (8) The researchers believe that they cannot enter the clinical researchers.

研究者

发起方
Guangdong Provincial Hospital of Chinese Medicine

相似试验